Bcl2-associated athanogene 3 (
In addition to the BAG domain, BAG3 contains also a WW domain and a proline-rich (PXXP) repeat, that mediate binding to partners different from Hsp70. These multifaceted interactions underlie BAG3 ability to modulate major biological processes, that is, apoptosis, development, cytoskeleton organization and autophagy, thereby mediating cell adaptive responses to stressful stimuli. In normal cells, BAG3 is constitutively present in a very few cell types, including cardiomyocytes and skeletal muscle cells, in which the protein appears to contribute to cell resistance to mechanical stress. BAG3 is expressed also in several tumor types where it sustains cell survival, resistance to therapy, and/or motility and metastatization .
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Description
The gene encompasses 33450 bases, 4 exons. 
Expression
Under physiological conditions, BAG3 expression appears to be restricted to few cell types including skeletal muscle cells and cardiomyocytes (Hishiya et al., 2010; De Marco et al., 2011; De Marco et al., 2013) . Its expression, however, can be induced in different normal cell types (leukocytes, epithelial, glial and retinal cells) by a variety of stressors, such as oxidants, high temperature, serum deprivation, and it is thought to contribute to stress resistance (Rosati et al., 2007; Pagliuca et al., 2003; Rosati et al., 2009; Ammirante et al., 2010) . In contrast to normal cells, BAG3 expression is abundant in several primary tumors or tumor cell lines, where it is thought to give a survival advantage . Among those melanoma cells, pancreatic adenocarcinoma cells, colon cancer, liver cancer, Tlynph Jurkat cancer, leukemias, kidney HEK-293, Lung A549, prostate cancer LnCap, cervix cancer Hela, bone cancer U20S, breast cancer cells MCF7.
Localisation
BAG3 is mainly a cytoplasmatic protein, particularly concentrated in the rough endoplasmic reticulum; a slightly different molecular weight, a doublet form or a nuclear localisation can be observed in some cell types and/or following cell exposure to stressors. BAG3 protein is also released from stressed cardiomyocytes and Pancreatic Adeno Carcinoma cells (PDAC) and can be detected in sera of patients with chronic heart failure (HF) or PDAC Falco et al., 2013) , as well as in cells surnatants.
Function
Through its BAG domain, BAG3 protein binds with high affinity to the ATPase domain of Hsc70 and regulates its chaperone activity in a Hip-modulated manner; through its PXXP region, BAG3 binds to the SH3 domain of PLC-gamma and forms an epidermal growth factor (EGF)-regulated ternary complex; the proline-rich repeat appears to be involved in regulating cell adhesion and migration, through an indirect effect on focal adhesion kinase (FAK) and its downstream partners; BAG3 knockout mice develop a fulminant myopathy; downmodulation of BAG3 protein levels enhance cell apoptotic response to several inducers, while hyperexpression protects cells from apoptosis. BAG3 levels increase during myoblast differentiation, suggesting that its biological role is relevant for differentiated myocytes and not for immature cells. This is in agreement with the observation that BAG3 deletion causes a lethal cardiomyopathy not in embryos, but in postnatal mice. BAG3 mutations may cause abnormal Z-disc assembly and sensitization to apoptosis in cultured cardiomyocytes. More recently it has been shown that BAG3 is essential for homeostasis of mechanically stressed cells. BAG3 is in fact an important component of the chaperone-assisted autophagy (CASA) pathway leading to selective lysosomal degradation of unfolded proteins. In muscle cells the CASA machinery is located at the Z-disk and appears to be essential for disposal of unfolded mechano-sensors and cytoskeleton proteins resulting from mechanical tension. Impairment of the CASA machinery results in zdisk disruption in contracting muscles (Ulbricht et al., 2013; Ulbricht and Höhfeld, 2013) .
Homology
Other members of BAG family.
Mutations
Note Several reports associate BAG3 mutations with myopathy. A mutated form of BAG3, i.e. heterozygous Pro209Leu, causes childhood cardiomyopathy and a severe and progressive muscle weakess (Selcen et al., 2009 ). Nonsynonymous BAG3 SNPs or others truncated BAG3 forms were reported to correlate with familiar dilated cardiomyopathy (Villard et al., 2011) and stress-cardiomyopathy also known as Takotsubo cardiomyopathy . Finally, two heterozygous BAG3 gene mutations, which cause abnormal Z-disc assembly and increased sensitivity to apoptosis in cultured cardiomyocytes, were identified in patients with familial DCM (Arimura et al., 2011) .
Implicated in
B-chronic lymphocytic leukaemia
Disease Expression of BAG3 gene in leukaemic cell samples from a study on 24 B-CLL-affected patients was detected by RT-PCR and immunofluorescence. Downmodulation of its levels by antisense ODNs resulted in enhancing cytochrome c release, caspase 3 activation and appearance of hypodiploid elements in response to fludarabine (Romano et al., 2003) .
Childhood acute lymphoblastic leukemia
Disease Expression of BAG3 gene in leukaemic cell samples from a study on 11 ALL-affected patients was detected by immunofluorescence. Downmodulation of its levels by antisense ODNs resulted in stimulating caspase 3 activity and enhancing by more than 100% the percentages of apoptotic elements in primary cultures, either untreated or incubated with cytosine arabinoside (Romano et al., 2003) .
Thyroid carcinomas
Disease BAG3 was expressed in human thyroid carcinoma cell lines; small interfering RNA-mediated downmodulation of its levels significantly enhanced NPA cell apoptotic response to TRAIL. The protein was not detectable in 19 of 20 specimens of normal thyroid or goiters, whereas 54 of 56 analyzed carcinomas (15 follicular carcinomas, 28 papillary carcinomas, and 13 anaplastic carcinomas) were clearly positive for BAG3 expression (Li et al., 2013) .
Pancreatic adenocarcinomas
Disease BAG3 protein is expressed in PDACs, but is not expressed in the surrounding nonneoplastic tissue. Survival is significantly shorter in patients with high BAG3 expression than in those with low BAG3 expression. Furthermore, BAG3 expression in PDAC-derived cell lines protects from apoptosis and confers resistance to gemcitabine, offering a partial explanation for the survival data. Indeed BAG3 has a relevant role in PDAC biology, and BAG3 expression level might be a potential marker for prediction of patient outcome Rosati et al., 2012) .
Colorectal carcinomas
Disease
Bag3 is distinctly expressed in Colo201, Colo205, DLD-1, HCT-15, HCT-116, HT-29, KM-12, SW480, SW620, and WiDr at both mRNA and protein levels. Carcinoma shows stronger Bag-3 expression than adjacent NNM by IHC and Western blot. Metastatic carcinoma more frequently expressed Bag-3 mRNA in lymph node and liver than in primary carcinoma. Immunohistochemically, Bag-3 expression is seen to gradually decrease from carcinoma, adenoma to NNM. There is a positive correlation between Bag-3 expression and TNM staging and GRP94 expression, but no relationship to patient age or sex, tumor size, depth of invasion, lymphatic or venous invasion, lymph node metastasis, differentiation or prognosis of colorectal carcinomas. Aberrant Bag-3 expression might be involved in colorectal adenoma-adenocarcinoma sequence and subsequent progression (Yang et al., 2013) .
